Arsenic Trioxide and Thalidomide in the Treatment of Refractory Multiple Myeloma

NCT00193544 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Arsenic Trioxide
DRUG: Thalidomide

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]